Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
Status:
Not yet recruiting
Trial end date:
2026-06-04
Target enrollment:
Participant gender:
Summary
This clinical trial aims to learn whether blood pressure (BP) guided by individualized
cerebral autoregulation (CA) is safe and provides a better prognosis than a fixed target in
patients with ischemic stroke after endovascular therapy. The BP of participants will be
managed at least 48 hours after revascularization. Researchers will compare the CA-guided BP
group with the fixed target BP group to mainly see if individualized BP could help more
patients to have their neurological function improved at seven days.